Vision/Mission
Contributing to the health of humankind through the development of revolutionary biotechnologies such as gene therapy.
Business Description
Takara Bio is working on three business sections as follows:
Bio Industory Business
Takara Bio develops original research reagents, scientific instruments, and contracted research services that utilize new genetic and cell engineering technologies on a consistent basis, supporting biotechnology research and bio industry around the world in fields that range from basic research to drug discovery and development.
Gene Therapy Business
With the aim of commercialization, Takara Bio uses biotechnologies developed over many years to advance the clinical development of gene therapies that target diseases such as a cancer.
AgriBio Business
Takara Bio works to discover the functionality of traditional Japanese food ingredients, and develops and produces functional foods that utilize these materials. It also cultivates new mushroom types and utilizes technologies for large-scale production to produce and market Honshimeji and Hatakeshimeji mushrooms.
Background
1979 Takara Shuzo Co., Ltd. (now, Takara Holdings Inc.) commenced sales of the first domestically produced restriction enzymes.
1988 Acquired exclusive distribution rights in Japan for a gene amplification system using PCR technology.
1993 Established Takara Biotechnology (Dalian) Co., Ltd. in China.
2002 Takara Bio was established as a result of corporate separation from Takara Shuzo.
2004 Takara Bio was listed on the Mothers section of Tokyo Stock Exchange.
2005 Acquired Clontech Laboratories, Inc. of the United States.
2014 Inauguration of the Center for Gene and Cell Processing in Kusatsu, Shiga, Japan.
2015 Moved headquarters from Otsu to Kusatsu, Shiga, Japan.
2016 Moved to the first section of the Tokyo Stock Exchange.
Products/Services
Research Reagent and Scientific Instruments
Restriction enzymes, PCR reagents, antibodies, cells, culture media, bags, PCR and real-time PCR equipment, mass spectrometry system, etc.
Research and Manufacturing Contracting Services
Genome analysis, iPS cell production, cell processing and preparation, vector production for gene therapy with GMP/GCTP quality, safety testing for cell products, etc.
Markets
Bio industry business
Cell and gene therapy business
Agri bio business
Industry
Biotechology
Location
Head Office:
Nojihigashi 7-4-38, Kusatsu, Shiga 525-0058, Japan
Subsidiaries (overseas):
Takara Biotechnology (Dalian) Co., Ltd. Dalian, China
Takara Korea Biomedical Inc. Seoul, Korea
Takara Bio USA Holdings Inc. Mountain View, CA, USA
Takara Bio USA,Inc. Mountain View, CA, USA
Takara Bio Europe S.A.S. St-Germain–en-Laye, France
Takara Bio Europe AB Gothenburg, Sweden
Takara Biomedical Technology (Beijing) Co., Ltd. Beijing, China
DSS Takara Bio India Pvt. Ltd. New Delhi, India
Employees
1,273 (consolidated, as of March 31, 2016)
